Clinical Trials | May 20, 2022
Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics
A primary investment of Rs 194.4 crore has been made
A primary investment of Rs 194.4 crore has been made
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
It is expanding the diagnostics business footprint in North East India
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Subscribe To Our Newsletter & Stay Updated
